Eric Ng

Eric Ng joined the Post in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a master's of business administration degree.
Eric Ng
Eric Ng joined the Post in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a master's of business administration degree.

Latest from Eric Ng

Foreign start-ups eye China’s vast digital health care market, but finding the right revenue model holds the key to success

Start-ups such as Boston-based Biofourmis have partnered with local health care platforms like Jianke, giving the company access to its vast customer base.

11 Jun 2019 - 11:14AM

Start-ups such as Boston-based Biofourmis have partnered with local health care platforms like Jianke, giving the company access to its vast customer base.

Foreign start-ups eye China’s vast digital health care market, but finding the right revenue model holds the key to success
Shanghai tech board unlikely to challenge Hong Kong’s status as preferred IPO hub for Chinese biotech firms

Investment bankers say the US-China trade war might dampen valuations of biotech companies looking to raise funds in Hong Kong, but their overall numbers are likely to remain intact.

3 Jun 2019 - 8:42AM

Investment bankers say the US-China trade war might dampen valuations of biotech companies looking to raise funds in Hong Kong, but their overall numbers are likely to remain intact.

Shanghai tech board unlikely to challenge Hong Kong’s status as preferred IPO hub for Chinese biotech firms
Chinese tariffs risk US$200 billion of US gas investments, may spoil America’s ambition to become top global exporter

Two-thirds of the 310 million tonnes of planned US LNG annual capacity, spread over 25 projects and requiring more than US$200 billion of investment, have not yet secured financing.

31 May 2019 - 2:12AM

Two-thirds of the 310 million tonnes of planned US LNG annual capacity, spread over 25 projects and requiring more than US$200 billion of investment, have not yet secured financing.

Chinese tariffs risk US$200 billion of US gas investments, may spoil America’s ambition to become top global exporter
China needs it, the US has it, but why might a trade war energy deal not be the easy win it appears to be?

The US will soon be a net exporter of energy, while China is the world’s biggest importer, suggesting it would be an easy part of a trade war deal to achieve.

31 May 2019 - 8:44AM

The US will soon be a net exporter of energy, while China is the world’s biggest importer, suggesting it would be an easy part of a trade war deal to achieve.

China needs it, the US has it, but why might a trade war energy deal not be the easy win it appears to be?
Caught between Trump and its biggest market, America’s sole rare earths mine is an unusual victim in the US-China trade war

The strategy of MP Materials underscores the lopsidedness in one aspect of the complicated US-China commercial relationship, where America had run a trade deficit with China since at least 1985.

27 May 2019 - 9:03AM

The strategy of MP Materials underscores the lopsidedness in one aspect of the complicated US-China commercial relationship, where America had run a trade deficit with China since at least 1985.

Caught between Trump and its biggest market, America’s sole rare earths mine is an unusual victim in the US-China trade war
Explainer: Can the US take back some control of rare earths from China?

China has retaliated against the US’s imposition of up to 25 per cent tariffs on US$200 billion worth of Chinese exports, by slapping duties on US$60 billion worth of US products from June 1, including rare earth products.

26 May 2019 - 8:00PM

China has retaliated against the US’s imposition of up to 25 per cent tariffs on US$200 billion worth of Chinese exports, by slapping duties on US$60 billion worth of US products from June 1, including rare earth products.

Explainer: Can the US take back some control of rare earths from China?
US-China trade war, financial transparency to spur more belt and road projects, says Standard Chartered

China’s commitment to adopt key elements of financial practices used by World Bank and IMF to ensure projects’ debt sustainability will lead to more lending opportunities in countries covered by belt and road, says banker.

20 May 2019 - 7:30AM

China’s commitment to adopt key elements of financial practices used by World Bank and IMF to ensure projects’ debt sustainability will lead to more lending opportunities in countries covered by belt and road, says banker.

US-China trade war, financial transparency to spur more belt and road projects, says Standard Chartered
Li Hejun, once China’s richest man, gets approval from shareholders to take troubled Hanergy unit private

Hanergy Thin Film’s shares were suspended four years ago when they suddenly shed about half their value in an hour

19 May 2019 - 10:30PM

Hanergy Thin Film’s shares were suspended four years ago when they suddenly shed about half their value in an hour

Li Hejun, once China’s richest man, gets approval from shareholders to take troubled  Hanergy unit private
How a Chinese company targeted by US tariffs for the last 10 years has adapted and thrived

Hilong Holding changed its US business model and looked to newer markets after anti-dumping duties were slapped on the Hong Kong-listed provider of oilfield equipment and services.

19 May 2019 - 10:29PM

Hilong Holding changed its US business model and looked to newer markets after anti-dumping duties were slapped on the Hong Kong-listed provider of oilfield equipment and services.

How a Chinese company targeted by US tariffs for the last 10 years has adapted and thrived
More Hong Kong insurers will cover pre-existing illnesses as new voluntary scheme highlights demand, says AXA executive

There’s a huge, unmet demand for health insurance for those with chronic pre-existing conditions in Hong Kong, says Alexander Chiu, a medical director with the insurance giant.

16 May 2019 - 8:41AM

There’s a huge, unmet demand for health insurance for those with chronic pre-existing conditions in Hong Kong, says Alexander Chiu, a medical director with the insurance giant.

More Hong Kong insurers will cover pre-existing illnesses as new voluntary scheme highlights demand, says AXA executive
Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model

Not only is the firm profit-making, but its investment in potential drug candidates has made it attractive to investors, says Louis Tse Ming Kwong, managing director of VC Asset Management

13 May 2019 - 9:30AM

Not only is the firm profit-making, but its investment in potential drug candidates has made it attractive to investors, says Louis Tse Ming Kwong, managing director of VC Asset Management

Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model
CLP’s plan to buy solar energy from village houses hits a snag

Of the 2,500 applications to sell renewable power to CLP, as many as 13 per cent may face delays or are indefinitely on hold

6 May 2019 - 9:56PM

Of the 2,500 applications to sell renewable power to CLP, as many as 13 per cent may face delays or are indefinitely on hold

CLP’s plan to buy solar energy from village houses hits a snag
Biotech start-up backed by Li Ka-shing and Bill Gates to launch its immunity-boosting gut bacteria in Hong Kong, Singapore

Evolve BioSystems’ dietary supplement works by reintroducing a beneficial gut bacteria that is missing in today’s babies

6 May 2019 - 6:00AM

Evolve BioSystems’ dietary supplement works by reintroducing a beneficial gut bacteria that is missing in today’s babies

Biotech start-up backed by Li Ka-shing and Bill Gates to launch its immunity-boosting gut bacteria in Hong Kong, Singapore
As biotechnology firms become the darlings of Hong Kong’s IPO market, their executives get outsized pay packets. Here’s why

As biotechnology becomes one of the hottest sectors in Hong Kong’s IPO market, biotech executives get extraordinary pay packages, especially in the first year after the companies go to market.

3 May 2019 - 12:04PM

As biotechnology becomes one of the hottest sectors in Hong Kong’s IPO market, biotech executives get extraordinary pay packages, especially in the first year after the companies go to market.

As biotechnology firms become the darlings of Hong Kong’s IPO market, their executives get outsized pay packets. Here’s why
Russia’s plans for Arctic gas may be an alternate source for China’s energy needs, sate Chinese appetite for US energy products

Russia’s agreement with Chinese state-owned oil companies to develop natural gas in the Arctic Circle could provide an alternative source for China’s energy needs

1 May 2019 - 10:04PM

Russia’s agreement with Chinese state-owned oil companies to develop natural gas in the Arctic Circle could provide an alternative source for China’s energy needs

Russia’s plans for Arctic gas may be an alternate source for China’s energy needs, sate Chinese appetite for US energy products
Hong Kong pharma start-up joins with Singapore technology agency in venture fund

Aptorum Group plans to invest alongside A*ccelerate Technologies in promising Singaporean health-care start-ups

28 Apr 2019 - 9:53PM

Aptorum Group plans to invest alongside A*ccelerate Technologies in promising Singaporean health-care start-ups

Hong Kong pharma start-up joins with Singapore technology agency in venture fund
Temasek unit-backed firm Lucence to tap Hong Kong cancer screening market

Lucence Diagnostics, a Singapore-based cancer screening and DNA testing company, is considering setting up a laboratory in Hong Kong to better compete in the liquid biopsy market.

26 Apr 2019 - 7:00AM

Lucence Diagnostics, a Singapore-based cancer screening and DNA testing company, is considering setting up a laboratory in Hong Kong to better compete in the liquid biopsy market.

Temasek unit-backed firm Lucence to tap Hong Kong cancer screening market
Bill Gates is backing this Hong Kong biotech start-up that can screen for cancer through a sample of urine or blood. Here’s why

Kwun Tong-based Phase Scientific International says it has developed a new method of sample preparation that addresses shortcomings in current screening procedures.

23 Apr 2019 - 1:14PM

Kwun Tong-based Phase Scientific International says it has developed a new method of sample preparation that addresses shortcomings in current screening procedures.

Bill Gates is backing this Hong Kong biotech start-up that can screen for cancer through a sample of urine or blood. Here’s why
Why is global investors’ fossil fuel divestment not having the desired effect on China’s carbon emissions?

More than 1,000 institutional investors have committed themselves to divest US$6.2 trillion from fossil fuel companies, but they are unable to pressure Chinese miners and power producers as they do not rely on foreign funds.

19 Apr 2019 - 12:00PM

More than 1,000 institutional investors have committed themselves to divest US$6.2 trillion from fossil fuel companies, but they are unable to pressure Chinese miners and power producers as they do not rely on foreign funds.

Why is global investors’ fossil fuel divestment not having the desired effect on China’s carbon emissions?
Hong Kong developer Henderson Land sells a third of 101 units at Yuen Long project

Just a third of the apartments on offer at Hong Kong developer Henderson Land’s Reach Summit project were snapped up on Tuesday, a reflection of buyers’ cautious outlook about the property market.

17 Apr 2019 - 2:57AM

Just a third of the apartments on offer at Hong Kong developer Henderson Land’s Reach Summit project were snapped up on Tuesday, a reflection of buyers’ cautious outlook about the property market.

Hong Kong developer Henderson Land sells a third of 101 units at Yuen Long project
Zurich-based robotics giant ABB expects Chinese electric vehicle makers and SME sector to keep Shanghai plant busy

ABB Group is banking not only on hundreds of electric vehicle start-ups in China, but also millions of its small and medium-sized manufacturers to fill up the order books at a robotics factory it is building in Shanghai.

14 Apr 2019 - 10:35PM

ABB Group is banking not only on hundreds of electric vehicle start-ups in China, but also millions of its small and medium-sized manufacturers to fill up the order books at a robotics factory it is building in Shanghai.

Zurich-based robotics giant ABB expects Chinese electric vehicle makers and SME sector to keep Shanghai plant busy
Big data enters the fray in the war against cancer as pharmaceutical laboratories combine drugs like cocktails to kill cancerous cells

There are millions of possible combinations of drugs that can be used to fight cancer, so pharmaceutical companies are making use of big data analysis and machine learning to plough through the data

7 Apr 2019 - 4:13PM

There are millions of possible combinations of drugs that can be used to fight cancer, so pharmaceutical companies are making use of big data analysis and machine learning to plough through the data

Big data enters the fray in the war against cancer as pharmaceutical laboratories combine drugs like cocktails to kill cancerous cells
Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?

Research and development costs run up against a ceiling over treatment prices, a very pertinent concern in China, where the government is anxious to keep health care affordable, in keeping with its socialist principle of governance

8 Apr 2019 - 10:46PM

Research and development costs run up against a ceiling over treatment prices, a very pertinent concern in China, where the government is anxious to keep health care affordable, in keeping with its socialist principle of governance

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?
This Guangzhou company has a strategy to help China’s state hospitals compete in the data economy

Haici is helping China’s state hospitals transition to online platform service providers

3 Apr 2019 - 5:42PM

Haici is helping China’s state hospitals transition to online platform service providers

This Guangzhou company has a strategy to help China’s state hospitals compete in the data economy
Softbank-backed firm wants to put 100,000 cloud-based robots in the market by 2021, to seek US$300 million in private funding

Cloudminds Technology, the Santa Clara, California-based developer of a cloud-based platform that aims to operate millions of intelligent consumer services robots one day, is looking to raise at least US$300 million.

29 Mar 2019 - 6:00AM

Cloudminds Technology, the Santa Clara, California-based developer of a cloud-based platform that aims to operate millions of intelligent consumer services robots one day, is looking to raise at least US$300 million.

Softbank-backed firm wants to put 100,000 cloud-based robots in the market by 2021, to seek US$300 million in private funding
China can excel in consumer robotics, says Credit Suisse Asset Management specialist

China can become a formidable player in the nascent consumer robotics market, where precision of movements is not as important as with industrial robotics, says Angus Muirhead, senior portfolio manager at Credit Suisse Asset Management.

28 Mar 2019 - 12:50PM

China can become a formidable player in the nascent consumer robotics market, where precision of movements is not as important as with industrial robotics, says Angus Muirhead, senior portfolio manager at Credit Suisse Asset Management.

China can excel in consumer robotics, says Credit Suisse Asset Management specialist
Chinese energy giant Sinopec defends 41 per cent increase in oil and gas exploration budget, says guided by market forces

Sinopec, one of China’s Big Three state-backed oil and gas producers and the world’s largest oil refiner, sought to allay concerns it was putting an order by Beijing to raise domestic output ahead of profitability.

25 Mar 2019 - 10:45PM

Sinopec, one of China’s Big Three state-backed oil and gas producers and the world’s largest oil refiner, sought to allay concerns it was putting an order by Beijing to raise domestic output ahead of profitability.

Chinese energy giant Sinopec defends 41 per cent increase in oil and gas exploration budget, says guided by market forces
Beleaguered Siberia iron ore miner gets boost from Brazil mine shutdowns

IRC, already benefiting from ‘Belt and Road Initiative,’ gets boost from big run-up in ore prices

24 Mar 2019 - 10:10PM

IRC, already benefiting from ‘Belt and Road Initiative,’ gets boost from big run-up in ore prices

Beleaguered Siberia iron ore miner gets boost from Brazil mine shutdowns
State energy giant PetroChina reports 130 per cent increase in net profit, eyes energy cooperation with US

PetroChina, the country’s largest oil and gas producer, will seek deeper ties with energy producers in the US, with the hope of playing a key role in helping the two countries resolve their trade war, its president said on Thursday.

21 Mar 2019 - 9:42PM

PetroChina, the country’s largest oil and gas producer, will seek deeper ties with energy producers in the US, with the hope of playing a key role in helping the two countries resolve their trade war, its president said on Thursday.

State energy giant PetroChina reports 130 per cent increase in net profit, eyes energy cooperation with US
CK Hutchison and CK Asset post upbeat profit results during Victor Li’s debut year as chairman
  • The listed flagship companies of tycoon Li Ka-shing reported improving profit for the period ending December 31
21 Mar 2019 - 10:50PM
  • The listed flagship companies of tycoon Li Ka-shing reported improving profit for the period ending December 31
CK Hutchison and CK Asset post upbeat profit results during Victor Li’s debut year as chairman